LinkedIn·Monday, 24 August 2026·2d ago
Our colleagues Christina Takke and Katja Rosenkranz will be attending Biocentury Grand Rounds on September 23rd-25th. Join us to discuss…
V-Bio Ventures
5,435 followers
Our colleagues Christina Takke and Katja Rosenkranz will be attending Biocentury Grand Rounds on September 23rd-25th. Join us to discuss what happens at the cutting edge of translational science and how to bring innovative medicines to patients.
♥ 32↻ 1
View on LinkedIn Cross-referenced
Related on the wire
V-Bio Ventures portfolio company Tanai Therapeutics just announced the appointment of Josua Jordi as its new CEO. We are excited to welcome…
Our partners Shelley Margetson and 🧪 Ward Capoen will be attending IPEM Global in Paris next month. Come say hello and learn about V-Bio…
another significant milestone for Agomab today. The company announces the design of its NOV-ERA Phase 2b study in Fibrostenosing Crohn's…
Setra returns to operating profit in Q2 Lower timber costs and efficiency gains helped the Swedish wood-products company improve sharply.…
When AI takes over the world: it will still need people - to produce electricity, as in the Matrix. Unless it switches to gas. Then AI will…
🤖 Physical AI is moving from the lab to the factory floor. At FairRobotics, we help industrial companies turn real workflows into…